Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

142.38 USD +0.73 (+0.52%)
Official Closing Price Updated: 7:54 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,427,400
Open 142.24
Bid (Size) 142.05 (1)
Ask (Size) 143.00 (1)
Prev. Close 141.65
Today's Range 141.72 - 144.70
52wk Range 106.25 - 170.75
Shares Outstanding 1,085,430,420
Dividend Yield 1.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status
- Jardiance (empagliflozin) reduced risk for the composite endpoint of cardiovascular death and hospitalization for heart failure, as well as serious adverse kidney outcomes, in adults with or without... 
From PR Newswire
Investor Alert: Kaplan Fox Investigates Eli Lilly For Potential Securities Fraud
Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors who purchased shares of Eli Lilly and Company ("Eli Lilly" or the "Company") (NYSE: LLY). 
From PR Newswire

Performance

YTD
+7.69%
+7.69%
1 Month
-4.96%
-4.96%
3 Month
-10.76%
-10.76%
6 Month
-12.61%
-12.61%
1 Year
+32.03%
+32.03%

More News

Read More
In Pursuit of the Elusive Drug -- the Billion-Dollar Blockbuster
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eli Lilly and Company - LLY
From PR Newswire
ELI LILLY AND COMPANY ALERT: Bragar Eagel & Squire, P.C. is Investigating Eli Lilly and Company on Behalf of Eli Lilly Stockholders and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
In Pursuit of the Elusive Drug — the Billion-Dollar Blockbuster
From InvestorBrandNetwork
Psychedelics Could Become the Next Health and Wellness Trend
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Psychedelics Could Become the Next Health and Wellness Trend
From PR Newswire
Eli Lilly Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Eli Lilly and Company To Contact The Firm
From NewMediaWire
The Law Offices of Frank R. Cruz Continues Its Investigation of Eli Lilly and Company (LLY) on Behalf of Investors
From Business Wire News Releases
Pfizer, Moderna Vaccines, Gilead Treatment In Focus As Health Firms Report Q3 Earnings
Tags REGN AZN THC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.